Brief: Phoenix Biotech Acquisition Corp Says On April 3, Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

CERo Therapeutics Holdings

07/04/2023 21:34

April 7 (Reuters) - Phoenix Biotech Acquisition Corp
 PBAX.O :
    * PHOENIX BIOTECH ACQUISITION CORP- ON APRIL 3, GOT NOTICE
OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ

Source text for Eikon:  ID: 
Further company coverage:  PBAX.O 

 ((Reuters.Brief@thomsonreuters.com;))